$BCDA
BioCardia, Inc.

2019 Q1 Form 10-Q Financial Statement

#000143774919010038 Filed on May 15, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q1
Revenue $216.0K $199.0K
YoY Change 8.54% 45.26%
Cost Of Revenue $106.0K $157.0K
YoY Change -32.48% -10.29%
Gross Profit $110.0K $42.00K
YoY Change 161.9% -210.53%
Gross Profit Margin 50.93% 21.11%
Selling, General & Admin $1.631M $1.707M
YoY Change -4.45% -5.38%
% of Gross Profit 1482.73% 4064.29%
Research & Development $2.166M $1.955M
YoY Change 10.79% 89.25%
% of Gross Profit 1969.09% 4654.76%
Depreciation & Amortization $23.00K $22.00K
YoY Change 4.55% 69.23%
% of Gross Profit 20.91% 52.38%
Operating Expenses $3.797M $3.662M
YoY Change 3.69% 29.08%
Operating Profit -$3.687M -$3.620M
YoY Change 1.85% 25.91%
Interest Expense $20.00K $40.00K
YoY Change -50.0%
% of Operating Profit
Other Income/Expense, Net $22.00K $36.00K
YoY Change -38.89% -3700.0%
Pretax Income -$3.670M -$3.580M
YoY Change 2.51% 24.31%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$3.665M -$3.584M
YoY Change 2.26% 24.62%
Net Earnings / Revenue -1696.76% -1801.01%
Basic Earnings Per Share
Diluted Earnings Per Share -$756.7K -$842.4K
COMMON SHARES
Basic Shares Outstanding 43.63M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q1 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.840M $9.650M
YoY Change -70.57% -49.29%
Cash & Equivalents $2.838M $9.653M
Short-Term Investments
Other Short-Term Assets $290.0K $280.0K
YoY Change 3.57% 12.0%
Inventory $118.0K $148.0K
Prepaid Expenses $277.0K
Receivables $287.0K $127.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.528M $10.21M
YoY Change -65.43% -47.8%
LONG-TERM ASSETS
Property, Plant & Equipment $175.0K $152.0K
YoY Change 15.13% -14.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $54.00K $54.00K
YoY Change 0.0% 0.0%
Total Long-Term Assets $1.629M $206.0K
YoY Change 690.78% -10.82%
TOTAL ASSETS
Total Short-Term Assets $3.528M $10.21M
Total Long-Term Assets $1.629M $206.0K
Total Assets $5.157M $10.41M
YoY Change -50.47% -47.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.139M $738.0K
YoY Change 54.34% 153.61%
Accrued Expenses $596.0K $579.0K
YoY Change 2.94% -19.58%
Deferred Revenue $118.0K
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.323M $2.121M
YoY Change 56.67% 55.04%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.020M $80.00K
YoY Change 1175.0% 33.33%
Total Long-Term Liabilities $1.020M $80.00K
YoY Change 1175.0% 33.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.323M $2.121M
Total Long-Term Liabilities $1.020M $80.00K
Total Liabilities $4.339M $2.204M
YoY Change 96.87% 54.13%
SHAREHOLDERS EQUITY
Retained Earnings -$90.03M -$75.99M
YoY Change 18.47% 20.58%
Common Stock $44.00K $38.00K
YoY Change 15.79% -91.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $818.0K $8.207M
YoY Change
Total Liabilities & Shareholders Equity $5.157M $10.41M
YoY Change -50.47% -47.37%

Cashflow Statement

Concept 2019 Q1 2018 Q1
OPERATING ACTIVITIES
Net Income -$3.665M -$3.584M
YoY Change 2.26% 24.62%
Depreciation, Depletion And Amortization $23.00K $22.00K
YoY Change 4.55% 69.23%
Cash From Operating Activities -$2.465M -$3.036M
YoY Change -18.81% 33.27%
INVESTING ACTIVITIES
Capital Expenditures $55.00K $5.000K
YoY Change 1000.0% -92.19%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$55.00K -$5.000K
YoY Change 1000.0% -92.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.000K
YoY Change -77.27%
NET CHANGE
Cash From Operating Activities -2.465M -3.036M
Cash From Investing Activities -55.00K -5.000K
Cash From Financing Activities 5.000K
Net Change In Cash -2.520M -3.036M
YoY Change -17.0% 30.86%
FREE CASH FLOW
Cash From Operating Activities -$2.465M -$3.036M
Capital Expenditures $55.00K $5.000K
Free Cash Flow -$2.520M -$3.041M
YoY Change -17.13% 29.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 bcda Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
1715000
CY2018Q4 bcda Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
1528000
CY2019Q1 bcda Accured Clinical Trial Costs
AccuredClinicalTrialCosts
363000
CY2018Q4 bcda Accured Clinical Trial Costs
AccuredClinicalTrialCosts
276000
CY2018Q1 bcda Cumulative Effect Of New Accounting Standard In Period Of Adoption
CumulativeEffectOfNewAccountingStandardInPeriodOfAdoption
46000
CY2019Q1 bcda Grant Liability Current
GrantLiabilityCurrent
638000
CY2018Q4 bcda Grant Liability Current
GrantLiabilityCurrent
645000
CY2019Q1 bcda Increase Decrease In Long Term Liabilities
IncreaseDecreaseInLongTermLiabilities
CY2018Q1 bcda Increase Decrease In Long Term Liabilities
IncreaseDecreaseInLongTermLiabilities
2000
CY2019Q1 bcda Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
126000
CY2018Q1 bcda Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
CY2019Q1 bcda Operating Lease Interest Expense
OperatingLeaseInterestExpense
45000
CY2019Q1 bcda Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
105000
CY2018Q1 bcda Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
CY2019Q1 bcda Operating Lease Variable Lease Expense
OperatingLeaseVariableLeaseExpense
75000
CY2019Q1 bcda Prepaid Expense And Other Current Assets
PrepaidExpenseAndOtherCurrentAssets
285000
CY2018Q4 bcda Prepaid Expense And Other Current Assets
PrepaidExpenseAndOtherCurrentAssets
445000
CY2018Q4 bcda Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
3800000
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
615000
CY2018Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
157000
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
3903000
CY2018Q1 us-gaap Costs And Expenses
CostsAndExpenses
3819000
CY2019Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
23000
CY2019Q1 us-gaap Inventory Net
InventoryNet
118000
CY2019Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
14
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
9
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8390945
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3878260
CY2018Q4 us-gaap Assets
Assets
6417000
CY2019Q1 us-gaap Assets Current
AssetsCurrent
3528000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
6218000
CY2019Q1 us-gaap Assets
Assets
5157000
CY2019Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1139000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1020000
CY2019Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
287000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
274000
CY2019Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
596000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
495000
CY2019Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
868000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
845000
CY2019Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
90800000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
90110000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
690000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
615000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
690000
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
77000
CY2019Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0
CY2019Q1 us-gaap Depreciation
Depreciation
23000
CY2018Q1 us-gaap Depreciation
Depreciation
22000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2838000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5358000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12689000
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9653000
CY2019Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2520000
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3036000
CY2018Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.75
CY2018Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2666666
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5333332
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43631684
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43611240
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43631684
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43611240
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
44000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
43000
CY2019Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
118000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
112000
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
106000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23000
CY2018Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
22000
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2019Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2018Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2019Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
5200000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
122000
CY2018Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-164000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
13000
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
32000
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-36000
CY2018Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
34000
CY2019Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
CY2018Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-35000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-23000
CY2018Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-43000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-160000
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-63000
CY2019Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9000
CY2018Q4 us-gaap Inventory Net
InventoryNet
141000
CY2019Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
82000
CY2018Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
79000
CY2019Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
27000
CY2018Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
39000
CY2019Q1 us-gaap Inventory Write Down
InventoryWriteDown
2000
CY2018Q1 us-gaap Inventory Write Down
InventoryWriteDown
2000
CY2019Q1 us-gaap Lease Cost
LeaseCost
225000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1738000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
649000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
630000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
459000
CY2019Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
253000
CY2019Q1 us-gaap Liabilities
Liabilities
4339000
CY2018Q4 us-gaap Liabilities
Liabilities
2625000
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5157000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6417000
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3323000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2548000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-55000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2465000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3036000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-3665000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-3584000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
22000
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
36000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3687000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3620000
CY2019Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
150000
CY2018Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
153000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1593000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1485000
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
469000
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1016000
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2019Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
CY2019Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
153000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1505000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1400000
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
CY2019Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1205
CY2019Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y273D
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1891000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
649000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
630000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
612000
CY2019Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
54000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
54000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000
CY2018Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
CY2019Q1 us-gaap Other Operating Income
OtherOperatingIncome
23000
CY2018Q1 us-gaap Other Operating Income
OtherOperatingIncome
36000
CY2018Q4 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
200000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
55000
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5000
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
CY2018Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5000
CY2019Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1043000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
990000
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
175000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
145000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2166000
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1955000
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-90026000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-86361000
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
216000
CY2018Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
199000
CY2018Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.75
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1631000
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1707000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
690000
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
615000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2961574
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.71
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5477364
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5477364
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.80
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.80
CY2019Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2019Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2019Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2019Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1000
CY2018Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
3792000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
818000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
11125000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
8207000
CY2019Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table style=";text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"><tr><td style="vertical-align:middle;width:5%;"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"></div> </td> <td style="vertical-align:top;width:3%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(c)</div></div></div> </td> <td style="vertical-align:top;width:92%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div> </td> </tr> <tr> <td style="vertical-align:middle;width:5%;">&nbsp;</td> <td style="vertical-align:top;width:3%;">&nbsp;</td> <td style="vertical-align:top;width:92%;">&nbsp;</td> </tr> <tr> <td style="vertical-align:middle;width:5%;">&nbsp;</td> <td style="vertical-align:top;width:3%;">&nbsp;</td> <td style="vertical-align: top; width: 92%; text-align: justify; padding-left: 18pt;">The preparation of the financial statements in accordance with U.S. GAAP requires management to make certain estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ materially from those estimates. Significant items subject to such estimates and assumptions include share-based compensation, the useful lives of property and equipment, allowances for doubtful accounts and sales returns, incremental borrowing rate, and inventory valuation.</td> </tr> </table></div></div></div>
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
43628958
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38236056

Files In Submission

Name View Source Status
0001437749-19-010038-index-headers.html Edgar Link pending
0001437749-19-010038-index.html Edgar Link pending
0001437749-19-010038.txt Edgar Link pending
0001437749-19-010038-xbrl.zip Edgar Link pending
bcda-20190331.xml Edgar Link completed
bcda-20190331.xsd Edgar Link pending
bcda-20190331_cal.xml Edgar Link unprocessable
bcda-20190331_def.xml Edgar Link unprocessable
bcda-20190331_lab.xml Edgar Link unprocessable
bcda-20190331_pre.xml Edgar Link unprocessable
bcda20190409_10q.htm Edgar Link pending
ex_144386.htm Edgar Link pending
ex_144387.htm Edgar Link pending
ex_144388.htm Edgar Link pending
ex_144389.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending